Trends of prevalent cancer incidences in the Aral-Syr Darya ecological area of Kazakhstan

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2299-2303

  Igissinov, Nurbek ^a,b   Igissinov, Saginbek ^a,c   Moore, Malcolm A ^d   Shaidarov, Mazhit ^b   Tereshkevich, Dmitriy ^b   Bilyalova, Zarina ^a,b   Igissinova, Gulnur ^a,e   Nuralina, Indira ^b   Kozhakhmetov, Saken ^b  

^a Central Asia Cancer Institute   (Kazakhstan)

^b ASTANA MEDICAL UNIVERSITY   (Kazakhstan)

^c ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY   (Kazakhstan)

^d UICC Asian Regional Office for Cancer Control   (Kazakhstan)

^e KAZAKH RESEARCH INSTITUTE OF ONCOLOGY AND RADIOLOGY   (Kazakhstan)

Author keywords

Aral Syra ecological zone, Kazakhstan; Incidence rates; Prevalent cancers; Trends

Indexed keywords

ARTICLE; ECOLOGY; FEMALE; HUMAN; INCIDENCE; KAZAKHSTAN; NEOPLASM; PREVALENCE; RETROSPECTIVE STUDY;

ECOLOGY; FEMALE; HUMANS; INCIDENCE; KAZAKHSTAN; NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84866271469     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. American Cancer Society (2009). Cancer facts and figures 2008, American Cancer Society, Atlanta. Available from: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf
2. Antunes JLF, Toporcov TN, De Andrade FP (2003). Trends and patterns of cancer mortality in European countries. Eur J Cancer Prev, 12, 367-72.
3. Berrino F, Sant M, Verdecchia A, editors (1995). Survival of cancer patients in Europe: The EUROCARE Study. Lyon (France): IARC Scientific Publication.
4. Boyle P, Autier P, Bartelink H, et al (2003). European code against cancer and scientific justification: third version. Ann Oncol, 14, 973-1005.
5. Demography Yearbook of Kazakhstan regions (2007). Statistical handbook. Astana, 392 p.
6. Demography Yearbook of Kazakhstan regions (2010). Statistical handbook. Astana, 637 p.
7. Ferlay J, Autier P, Boniol M, et al (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, 18, 581-92.
8. Glantz S (1999). Medical-biological statistics. Monograph, Moscow, 460 pp.
9. IARC (2003). Cancer Incidence in Five Continents//Eds.: D.M. Parkin, S.L. Whelan, J. Ferlay et al. IARC, Lyon, Vol. VIII.
10. IARC (2010). GLOBOCAN 2008: Cancer incidence and Mortality Worldwide in 2008: IARC CancerBase No. 10. Available from: http://globocan.iarc.fr Accessed: July 29, 2011.
11. MEPs against cancer (2011). Cancer facts and figures. Available from: http://www.mepsagainstcancer.org
12. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2004). Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer, 111, 981.
13. Levi F, Lucchini F, Negri E, et al (2004). Trends in cancer mortality in the European Union and accession countries, 1980-2000. Ann Oncol, 15, 1425-31.
14. MEPs against cancer (2011). Cancer facts and figures. Available from: http://www.mepsagainstcancer.org Merkov AM, Polykov LE (1974). Sanitary statistics. Monograph, Leningrad, 384 pp.
15. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55,74-108.
16. World Health Organization Statistical information System (2011). WHO mortality database. Available from: http://www3.who.int/whosis/whosis/menu.cfm.
17. Zaridze DG (2002). Epidemiology, mechanisms of cancer genesis and prevention. Arch Pathol, 2, 53-61.